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Abstract 
Of late, several biologically active antioxidants from natural products have been 
investigated by the researchers in order to combat the root cause of carcinogenesis, 
i.e., oxidative stress. Mangiferin, a therapeutically active C-glucosylated xanthone, is 
extracted from pulp, peel, seed, bark and leaf of Mangifera indica. These polyphenols 
of mangiferin exhibit antioxidant properties and tend to decrease the oxygen-free 
radicals, thereby reducing the DNA damage. Indeed, its capability to modulate 
several key inflammatory pathways undoubtedly helps in stalling the progression of 
carcinogenesis. The current review article emphasizes an updated account on the 
patents published on the chemopreventive action of Mangiferin, apoptosis induction 
made on various cancer cells, along with proposed antioxidative activities and 
patent mapping of other important therapeutic properties. Considering it as 
promising polyphenol, this paper would also summarize the diverse molecular 
targets of Mangiferin. 
Keywords: Chemoprotective, Antioxidants, Anti-inflammatory, Apoptosis, 
Bioactive, Patent mapping, Multiple molecular targets, Extraction and isolation of 
polyphenols, Isomangiferin, Homomangiferin,         
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1. Introduction 
Cancer has been affecting mankind since decades. Repeated victims of this most 
devastating disease are vital organs like lung, liver, breast, colorectum, prostate, 
oesophagous and stomach. It has been spreading like havoc and is expected to 
take tens of millions newer patients into the fold by 2020 [1]. The key element 
significantly aggravating cancer is oxidative stress. Primarily, the inability of the 
body to detoxify the generated free radicals leads to cancer. A great deal of 
research has been undertaken across the global laboratories to combat this deadly 
disease. Even after enormous efforts and dedicated research conducted in this 
domain, the struggle to beat cancer still seems to be an ongoing process, if not a 
distant dream. Although various anticancer drugs, incorporated in various 
delivery systems are continuously being introduced in the market, yet each one is 
associated with the vital concerns of poor bioavailability, high cost, accompanied 
with off-target side effects [2]. Antioxidants, in this regard, have caught the 
clairvoyant eye of researchers for their chemopreventive usage against cancer. 
Many biologically active antioxidants extracted from diverse flora have been 
explored and identified by the academicians and industrial researchers. 
Fundamentally, these tend to scavenge the free radicals by interrupting the 
oxidative chain reactions [3]. 
One of the naturally occurring glycosylxanthone that has gained rapid 
importance recently, in this context is Mangiferin (Mgf). It is a polyphenolic C- 
glycoside, basically extracted from the leaves, stem barks and fruits of Mango 
tree, Mangifera indica from Anacardiaceae family. It is a heat-stable molecule with 
molecular weight less than 500 daltons. It has attracted the attention of the 
scientists  worldwide, as it possesses numerous pharmacological activities other 
than acting merely as an antioxidant [4]. It is known to be an anti-inflammatory, 
anti-viral, analgesic, immunomodulatory [5] [6], antidiabetic [7] and many more. 
Several literature instances have cited and reported the ability of Mgf to inhibit 
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the cancer cells by inducing apoptosis.  It has been observed in various animal 
models that it could act as a potent antioxidant by reducing free radical species, 
thereby preventing the potential DNA damage [8]. Currently, Mgf is in advanced 
preclinical stages and its formulations are set to undergo clinical trials 
subsequently. The current review article will highlight the patents filed on Mgf 
emphasizing its role not only as an antioxidant, but also to uncover its other 
beneficial characteristics, propagating it as a promising futuristic bioactive. 
2. Source of Mangiferin: Extraction and Isolation  
Owing to its myriad pharmacological activities and easy availability, Mgf has 
allured the interest of the researchers to develop efficient extraction and isolation 
methods, which could result in its maximum yield. The prime source of Mgf is 
mango tree, which is found abundantly in nature [9]. Various ancient scriptures talk 
about the potential of this plant with high nutritive and medicinal values, associated 
with variegated families like Anacardiaceae [10], Podalyfrieae [11], Hypericoideae 
[12], etc (Figure 1). 
 
                                         
 
Figure 1: Existence of Mangiferin in three families. 
Mgf can be extracted easily through decoctions and infusions of mango because of 
its hydrophilic nature. Various methods have been described in literature for the 
extraction and isolation of Mgf from diverse plant parts of mango. Some of the 
methods opted are Soxhlet extraction, microwave-assisted extraction, and subcritical 
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extraction using solvents. However, the pitfalls associated with the use of these 
traditional techniques are the usage of high amount of solvents for extraction, more 
time consumption and economically less feasible [13]. To overcome these hiccups, 
various new techniques like supercritical fluid extraction (SFE) [14] and pressurized 
liquid extraction (PLE) [15], have been lately opted by researchers to obtain maximal 
yield in shorter time span. These techniques are preferred, as these processes are fast 
and environment friendly owing due to usage of green solvents such as carbon 
dioxide (CO2), ethanol or water.  Fernández-Ponce et al. (2012) reported subcritical 
water extraction method for the extraction of Mgf from varied plant varieties like 
Osteen, Kensington, Kent and Ataulfo. The extract showed highly potent in vitro 
antioxidant activity [13].  However, another scientific group, Kim et al., reported the 
extraction of Mgf from Mahkota Dewa employing same methodology, but making use 
of supercritical fluids [16]. Most commonly employed supercritical fluid is 
supercritical carbon dioxide (scCO2), as it is documented to be ecologically safe, non-
toxic and readily available [17]. The extraction yield from subcritical water method 
has been found to be quite close to the extraction yield using methanol as the 
extraction solvent, i.e., 21.7 mg/g [16]. Vrushali and Rathod (2014) described 
ultrasound three phase partitioning (UTPP) method for the extraction of Mgf from 
mango leaves. The method indicated the highest yield of 41 mg/g in 25 min vis-á-vis 
the conventional three-phase partitioning (TPP) that reported a yield of 28 mg/g  
in 2 h.  The latter offers a swift and economical technique for extraction of Mgf  [18].  
Further, Kulkarni and Rathod in 2015 reported the microwave assisted three phase 
partitioning extraction (MTPP) method. The results obtained indicated higher yield 
of Mgf by MTPP (95%) in 5 mins as compared with the conventional technique like 
Soxhlet extraction which usually requires around 5 h. As per the results obtained, 
the MTPP method proved to be more proficient and faster for extraction of Mgf [19]. 
In general, it is reported that the content of Mgf in various parts of Mango tree is 
approximately found to be 4.4 mg/kg in mango pulp [20], 42 mg/kg in seed kernel 
[21], 1690 mg/kg in mango peel [22] and most abundant 71.4 g/kg in stem bark [23]. 
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Therefore, the usage of newer techniques holds tremendous promise to provide 
maximal yield for wider exploration at lab and industrial scales. 
 
3. Structural elucidation and other isoforms   
To chemically synthesize Mgf being quite tedious as well as expensive, the best way 
to obtain it is considered to be via its extraction from various biological sources. 
Chemically, Mgf is C2-D-glucopyranosyl-1,3,6,7- tetrahydroxyxanthone as shown in 
Figure 2.   
                             
 
Figure 2. Structure of Mangiferin 
 
In its chemical structure, C-glucosyl xanthone contains aromatic ring attached to the 
C-C bond of a glucose moiety, contributing towards its high polarity and water 
solubility. By and large, Mgf gratify Lipinski’s rules, as for properties like molecular 
weight less than 500 with log P 2.73, fewer donor viz. acceptor groups, i.e., less than 
5 and 10 to suffice hydrogen bonding; thus signifying the possible modifications that 
can be accomplished by the medicinal chemists to alter its physiochemical properties 
[24]. The presence of catechol ring, free hydroxyl groups, redox active aromatic 
system due to xanthone moiety, is responsible for the antioxidant activity of Mgf. In 
addition, it possesses proficient iron-chelating properties, resulting in the prevention 
of  hydroxyl radicals  to go in Fenton-type reactions principally responsible for 
oxidation [9]. 
The other isomeric forms like isomangiferin and homomangiferin are also present 
along with Mgf in the mango plant. The co-occurrence of these xanthones was 
reported earlier in 1975 by Saleh and El-Ansari. Isomangiferin, mostly present in 
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Anemarrhena asphodeloides, chemically represented as 4-β-D-glucopyranosyl- 1, 3, 6, 7-
tetrahydroxy-9H-xanthen-9-one [25] whereas homomangiferin is 1,6,7-trihydroxy-3-
methoxy-2-C- β -D-glucopyranosyl-xanthone (Figure 3 a,b).  
 
 
                       
 
Figure 3. Mangiferin isomeric forms a) Isomangiferin b) Homomangiferin 
 
4. Mechanism of action: As an antioxidant 
The antioxidant potential of this xanthone derivative has been well established over 
the years. As already stated, polyphenols contribute to its free radical scavenging 
properties by arresting the generated free radicals. The possible responsible 
mechanistic pathways for the same include, the formation of iron chelates, inhibiting 
lipooxygenases and scavenging free radicals [26].  
Iron is an essential micronutrient that plays a key role in normal cellular physiology. 
Once the concentration of iron reaches the threshold level, it may result in the 
generation of catalytic response towards formation of oxyradicals. These free 
radicals have the ability to disrupt the cellular membrane lipids, nucleic acid chains, 
carbohydrates and proteins, ultimately impairing the normal cellular functions of 
body [27]. Mgf, in this regard may reduce the oxidative damage by forming iron 
chelates. It is well-documented that noranthyriol, a product of Mgf metabolism, 
exhibits strong iron-chelating property [26]. It was been found that Mgf preserves 
the integrity of mitochondrial membrane by protecting it from lipid peroxidation. 
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Gilberto et al. (2007) reported that Mgf-Fe(III) complex protects the mitochondrial 
membrane thiols and glutathiones from oxidation [28]. Mgf, by scavenging these 
reactive species, maintains cellular integrity, thus minimizing the possible damage to 
erythrocytes [4]. 
 
5. Targets for antioxidant properties of Mgf: Molecular level 
Since ages, polyphenols are known to modulate multiple molecular targets and 
signalling pathways. Mgf, serving as a potent polyphenol, has been shown to affect 
several biological processes, like inhibition of NF-kB and other transcription factors, 
reactive oxygen species (ROS), angiogenesis, and apoptosis including mitochondrial 
bioenergetics [29]. It is reported that the anticancer activity is achieved by cell cycle 
arrest and direct apoptosis, while its chemoprotective action could be attributed due 
to its antioxidant and anti-inflammatory activities [30]. These targets enable the 
chemopreventive actions of Mgf by inhibiting the initiation, promotion and 
metastasis of cancer.  Figure 4 and Table 1 highlights the various targets aimed by 
Mgf to curb cancer. 
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Figure 4. Diverse mechanisms for potential activity of Mangiferin 
 
 
 
   Table 1: Various molecular targets of Mgf to curb cancer 
 
      Target Biochemical markers References 
Reactive oxygen species (ROS): 
Mgf is known to scavenge ROS 
generated in the cells. It is also 
known to inhibit xanthine 
oxidase, the enzyme responsible 
for oxidation. 
ROS ↓  
[31-33] 
 
Anti-inflammatory:  
Mgf is a potent inhibitor of 
NFκB, IL-6, IL-8, CXCR4, XIAP, 
TNF, ICAM1 and COX2. 
NF-ĸB ↓  
[34] 
 
IκB-α ↓ 
JAK1/2 ↓ 
STAT3 ↓ 
AKT ↓ 
MAPK ↓ 
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IKK ↓ 
Anti-angiogenesis:  
Mgf exhibits anti-angiogenic 
activity by inhibiting the 
growth of some tumors. 
VEGF ↓  
[35, 36] TNFα ↓ 
B16F10 ↓ 
FGF ↓ 
Apoptosis:  
Mgf induces apoptosis by 
suppressing NF-κB activation 
and expressions of Bcl-xL and 
XAIP. 
Caspase 
9,7,3 
↑  
[37-41] 
 XIAP ↓ 
Bcl2 ↓ 
Bcl-xL ↓ 
PARP ↑ 
Metastasis:  
Mgf inhibits the activation of β-
catenin pathway and thus acts 
as an effective chemopreventive 
agent against breast cancer. 
MMP 7-9 ↓  
[42] 
 
COX2 ↓ 
VEGF ↓ 
ICAM ↓ 
E-cadherin ↑ 
Cell cycle arrest:   
Mgf could delay S-phase, arrest G2/M phase, leading to 
apoptosis. Mgf triggers cell-cycle arrest via down-regulating 
cdc2-cyclinB1 signalling pathway in breast cancer cells. 
[40, 43]  
Lipid peroxidation:  
Polyphenols could inhibit the onset of lipid peroxidation and 
evidently increase the serum antioxidant capacity, thus 
accounting for its chemopreventive action. 
[44] 
Mitochondrial membrane potential:   
Mgf induces loss of mitochondrial membrane potential and 
activates apoptotic proteins.  
[45] 
 
Apart from acting as antioxidant, Mgf possesses a repertoire of other useful 
properties. The specific patents in the light of each property have been obtained, and 
discussed underneath. 
1. Cosmeceuticals: Gupta et al., 2004 invented a novel ion-pair delivery system in 
which a charge donor and a charge acceptor composition have been combined 
synergistically to enhance bioavailability, deposition, functional performance, and 
consumer aesthetics. This variegated composition was found to be safe and effective 
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with antioxidants such as non-sulfhydryl donating groups which can enhance skin 
whitening efficacy [46]. 
Further, Gupta and Shyam  (2006) explored efficacy of hydroxy acids esters as 
topical compositions serving as beneficial cosmetic and pharmaceutical agents [47]. 
Another invention by Peter and associates (2013) incorporates topically bioavailable 
antibacterial agent, Mgf, as antioxidant agent which could improve micro-
circulation. The combination cures acne, rosacea, controls excess sebum production 
and undesirable growth of bacteria or mites, as well as enhanced desquamation of 
follicular infundibulum cells [48].  
Gupta and associates also disclosed an invention, with chirally correct polyene 
cyclodextrin acetals, and hemiacetals incorporated with antioxidants and anti-
inflammatory ketones, that were effective in providing skin clarification and 
disfigurements, treat acne, and lighten skin darkening resulting from cancer, 
diabetes, radiation treatments and chemotherapy [49]. 
2. Arthiritic disease: Park Dong-Suk et al., 2009 unravelled an invention comprising 
of the extract of Mgf mixed herbs with Lonicera japonica and Anemarrhena 
asphodeloides showing potent anti-inflammatory activity for safe and effective 
management of arthritis. The extract contained chlorogenic acid, besides Mgf as the 
standard component [50]. 
3. Breast cancer: Wang Ching-chiung in 2011 disclosed an ethyl acetate layer of 
methanolic extract of Aquilaria hulls for preventing cancer. The invention was tested 
on a group of cancer cell lines like colorectal, gastric, prostate, breast, pancreatic, 
lung, bladder, colon, cervical and hepatocellular carcinoma [51]. Truog and 
Buschmann (2014) invented a pharmaceutical composition comprising of 
phenylbutyric acid derivative, and a chemopreventive agent thereof for use in the 
prevention of cancer [52]. 
Also, Halbrook (2013) documented Mgf as a compound and in compositions which 
could inhibit DNA-dependent protein kinase (DNA-PK). The present DNA-PK 
inhibitors can be used as diagnostic and therapeutic methods useful in the field of 
cancer therapy. The reduced exposure to radiation and chemotherapy drugs 
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improves a patient's prognosis with regard to unwanted adverse side effects that 
often accompany cancer treatments [53]. 
 
4. Colon and Lung cancer: Wang (2012), disclosed that an ethyl acetate layer of 
methanol extract of Aquilaria hulls effectively kills the cancerous cells. The extracts of 
the same has significant amount of cucurbitacins, which are effective in 
treating/preventing cancers  [51]. Another research conducted by Siegelin and 
Altieri (2011) revealed a method of enhancing apoptosis in one or more mammalian 
cells, with at least one mitochondrial-targeted chaperone inhibitor and at least one 
agent selected from the group consisting of a death receptor agonist, an autophagy 
inhibitor, and a NF-κB signalling pathway inhibitor, i.e., Mgf [54].  
Further, Gerk in 2013, proposed a method for enhancing the bioavailability of orally 
bioactive phenolic compounds incorporated with one or more inhibitors like 
presystemic metabolism sulfotransferase (SULTs). Another clinical utilities of Mgf 
include diabetes,  hyperlipidemia, cholestasis, obesity, metabolic syndrome, various 
cancers, inflammatory diseases, arthritis and anti-aging activities [55]. Meanwhile, 
surmounthing the above inventions, Huang and Wu in 2014 discovered a novel 
method for treating gastrointestinal spasm in a subject having Crohn's disease or 
ulcerative colitis. The method comprised of administering an effective amount of 
water soluble polyphenols consisting of tannins [56].  
5. Leukemia: Khwaja and Friedman (1999) invented a delivery system comprising of 
St. John's Wort materials and unearthing methods for preparing medicinally useful 
and pharmaceutically acceptable forms which could determine the degree of the 
given biological activity for each of the marker fractions to provide a bioactivity 
fingerprint of the representative aliquot [57]. 
6. Multiple myeloma: Leonard (2011) disclosed a method for treating autoimmune 
conditions by administering a formulation comprising of mammalian IL-12 
antagonist administered during autoimmune conditions, where there is an increase 
in the levels of IFN-γ or TNF-α. The said formulation has been prescribed 
particularly during multiple sclerosis, systemic lupus erythematosus, rheumatoid 
arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, 
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autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune 
inflammatory eye disease [58]. 
7. Hepatocellular: Omoigui (2006) invented novel compositions and methods 
containing Mgf for preventing and treating disorders like atherosclerosis, peripheral 
vascular disease, coronary artery disease, osteoporosis, type 2 diabetes, dementia 
and various forms of arthritis. Therapeutically effective dosage forms reported in 
literature for cancer primarily consist of Mgf in combination with statins, 
bisphosphonates, cholesterol lowering agents or techniques, interleukin-6 inhibitor, 
oligonucleotides, tyrosine kinases inhibitors and nuclear factor-κB (NF-κB) inhibitors 
etc [59]. 
8. Skin cancer: Huang and Wu (2014) investigated some polyphenols as antioxidants 
to scavenge unwanted reactive oxygen species which can affect cell-to-cell 
signalling, receptor sensitivity, inflammatory enzyme activity and even gene 
regulation in animals [60, 61]. Further, Gupta (2009), reported salient features of 
water insoluble polycyclic polyisoprenoids conjugated with sugar esters, wherein 
the alcohol part, and the sugar lactone moiety of said sugar esters are useful for 
treating multiple skin conditions and ailments [62].  
9. Ovarian and Prostate cancer: Dasse (2008) reported that Mgf and various other 
antioxidants could inhibit the fatty acid amide hydrolase (FAAH) activity which 
could otherwise lead to increased levels of fatty acid amides to very well manage the 
ovarian cancer [63]. Supporting the same, Huang (2014) also provided methods 
incorporating these antioxidants that could treat and provide relief from prostate 
cancer pain [64]. 
Table 2 highlights various patents published, promoting the other fascinating 
properties of Mgf.   
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Table 2:  Patents emphasizing the captivating properties of Mangiferin 
 
S. 
No. 
Title Application 
number 
Publication 
date 
Inventors Details Reference 
1.  Analgesic 
 
KR2014/00125
2 
10/30/2014 Kim Dong Hyun;  
Han Myung Joo  
Neomangiferin, extracted from 
Rhizoma coptidis, can excellently 
prevent as well as treat colitis in 
animal models. Also it could be 
used be used as an ingredient for 
food and pharmaceuticals. 
[65] 
 
2.  Anthelminthic 
 
EP2009/05434
9 
10/15/2009 Talamond 
Pascale Chênes; 
Verts Eyragues;  
Mondolot 
Laurence 
Mourèze; 
Gargadennec 
Annick;  
De Kochko  
Alexandre; 
Hamon Serge; 
Fruchier Alain 
Fontaine; 
Montarnaud  
Campa Claudine  
Glycosyl xanthone derivatives, 
particularly Mgf and 
isomangiferin extracted from 
plants of the Rubiaceae family, 
especially of the Coffea genus has 
proven medicinal properties. 
[66] 
 
3.  Antiallergic 
 
JP2009/066203 04/01/2010 Fujifilm 
Corporation 
 
Pulverized product has been 
extracted from the genus Salacia 
and has proved to be an 
[67] 
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UEDA, Fumitaka; 
Kakinuma 
Chihaya,  
Serizawa, Yuriko  
immunopotentiator and 
antiallergic agent. 
4.  Antiamoebic 09/728051 09/02/2003 Winter Rolf W;  
Riscoe Michael 
K; Hinrichs, 
David J.  
Xanthone derivatives, such as 3,5-
bis-ε-(N,N-diethylamino) 
amyloxyxanthone, acts on 
Plasmodium falciparum and 
Leishmania Mexicana.  These 
compositions are additionally 
useful for forming soluble 
complexes with heme and 
porphyrins. 
[68] 
 
5.  Anti-
artherosclerosis 
14/547537 05/21/2015 Deshpande 
Jayant; 
Ghanam Khadija; 
Ewart Stephen; 
Juturu Vijaya  
A Salacia composition activates 
hormone sensitive lipase, and 
manages a healthy lipid profile 
through inhibition of HMG-CoA 
reductase enzyme. 
[69] 
 
6.  Antibacterial 
 
13/440446 07/26/2012 Gupta Shyam K. The present invention discloses 
certain derivatives of artemisinin 
and the active principles 
contained in Artemisia 
annua extracts with amino acids, 
peptides, amino sugars, and the 
salts thereof. The compounds of 
the present invention possess 
wide-spectrum antibacterial and 
antifungal activities. 
[70] 
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7.  Antidiabetic 13/063804 04/24/2012 Krishnan Geetha 
G. 
An herbal formulation for 
prevention and treatment of 
diabetes and associated 
complications, comprising of 
extracts from selected Indian 
medicinal herbs. 
[71] 
 
8.  Antifungal 12/116040 08/28/2008 Krishnan 
Venkataram  
This invention relates to the field 
of polymeric materials that can be 
used in combination with a wide 
variety of antioxidants. 
[72] 
 
9.  Anti-hypertensive 14/084793 03/27/2014 Auriol Daniel; 
Nalin Renaud;  
Robe Patrick 
Lefevre Fabrice 
The invention relates to the 
preparation of phenolic 
derivatives by enzymatic 
condensation of phenolics 
selected among pyrocatechol or 
its derivatives with the glucose 
moiety of sucrose as 
antihypertensive and 
cardioprotective agent 
[73] 
 
10.  Anti-
inflammatory 
JP20070001878
37 
02/05/2009 Matsuda 
Hideaki; 
Nishida Shozo  
The antiphlogistic agent as the 
remedy of the inflammatory 
diseases like arthritis comprise of 
Mgf as an active ingredient. 
[74] 
 
11.  Antimicrobial  12/116006 09/25/2008 Krishnan 
Venkataram 
This invention relates to the field 
of polymeric materials that can be 
used in combination with a wide 
variety of substrates, to act as 
antimicrobial, antibacterial, and 
[75] 
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antifungal agents. 
12.  Antioxidant 13/084709 07/03/2012 Gupta Shyam K; 
Walker Linda  
This invention relates to certain 
amides of amino acids, peptides, 
and amino sugars along with 
anti-inflammatory, agents like 
Mgf, inhibiting the concomitant 
onset of intra-cellular 
inflammation including 
activation/inactivation of matrix 
metalloproteases (MMP), 
tyrosinase, proteasomes, and 
other enzymes in mammals. 
[76] 
 
13.  Antiproliferative 13/023594 06/30/2011 Hoffmann Erika; 
Horres Roland; 
Faust Volker;  
Schreiber 
Helmut;  
Von Holst Armin; 
Hoffmann 
Michael 
The present invention is directed 
to a method for coating catheter 
balloons with a defined amount 
of a pharmacologically active 
agent like Mgf as an 
antiproliferative agent. 
[77] 
 
14.  Antiviral PCT/US2005/
047105 
07/27/2006 Ghosal Shibnath  The present invention relates to 
pharmaceutical or nutritional 
compositions of polyherbal 
extracts useful as anti-viral or 
immune-supporting agents ideal 
during the maintenance phase of 
the treatment, following an initial 
viral load reduction phase in 
[78] 
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which it is used as an adjuvant to 
conventional anti-viral drug 
therapy. 
15.  Arthritic 
 
12/865995 01/06/2011 Park Dong-suk;  
Yoo Myung; 
Chul; Choi Do-
young; Yang 
Hyung; Baek 
Yong-hyeon; 
Huh Jeong-eun;  
Kim Kyoung Soo;  
Cho Yong-baik;  
Jung In Ho; 
Hur Jong Hyun;  
Lee Jae Dong  
The saponins, Mgf and 
isomangiferin, help in inhibition 
or prevention of arthritic 
diseases. 
[79] 
 
16.  Cardioprotective 
 
13/063804 09/29/2011 Krishnan Geetha 
G 
Many of the existing antidiabetic 
drugs lead to drug resistance in 
patients, where and the isoforms 
of Mgf have proved to be quite 
efficacious. 
[80] 
 
17.  Gastroprotective 
 
13/772264 05/06/2014 Huang Alexander 
L; Wu Gin  
Antioxidant and anti-
inflammatory activities of Mgf 
are quite useful for treating 
gastrointestinal spasm. 
[81] 
 
18.  Immunomodulato
ry 
 
AU2013/00030
3 
09/26/2013 Thomas Ranjeny For treating or preventing joint 
damage, Mgf could elicit an 
antigen-specific tolerogenic 
response. 
[82] 
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19.  Lipolytic IB2014/002990 05/28/2015 Deshpande 
Jayant; Khadija; 
Stephen; 
Juturu Vijaya 
Polyphenols, extracted from 
Salacia composition described 
herein, significantly reduce 
appetite, activate hormone- 
sensitive lipase, and manage a 
healthy lipid profile through 
inhibition of HMG-CoA 
reductase enzyme, responsible 
for cholesterol metabolism. 
[83] 
 
20.  Neuroprotective 12/159781 05/21/2009 Matute Almau; 
Carlos  
Gomez; Maria 
Victoria Sanchez; 
Esparza Rosario 
Campos; Alfonso 
Elena Alberdi; 
Gottlieb 
Miroslav; 
Bilbao Gaskon 
Ibarretxe; Garcia 
Jose Maria 
Delgado; 
Gruart Masso 
Agnes I;  
Leal Campanario, 
Rocio 
The invention relates to the use of 
morin and Mgf for the treatment 
of a neurodegenerative disease 
and symptoms associated with 
ageing. 
[84] 
 
21.  Prevent 
osteoporosis 
PCT/GB2004/
001695 
11/04/2004 Chambers 
Timothy John; 
Fuller Karen; 
Bone loss disorders can be treated 
or prevented by administration of 
an agent which increases the 
[85] 
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Jagger 
Christopher 
John; Lean Jenny 
Maree 
levels of oxidant defences. 
22.  Radioprotective PCT/US1997/
006988 
10/23/1997 Khwaja Tasneem 
A; Friedman 
Elliot P 
The botanical extracts are not 
only medicinally and 
pharmaceutically acceptable but 
also enable the subsequent 
fingerprints in the processing of 
botanical materials to produce 
drugs which could be 
radioprotective. 
[86] 
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6. Conclusion and Future Prospects: 
 
Albeit the literature available so far on Mgf is scanty, yet every single piece of 
information filed, confirms its significant effect on fundamental biological events 
and processes like stimulating mitochondrial respiration, while suppressing 
oxidative stress and inflammation. In the light of the above, the current review has 
attempted to summarize reported patents on chemopreventive and curative 
potential of Mgf. Its pivotal role to suppress multiple molecular targets in both 
chronic inflammation and cancer has also been highlighted. Apart from that, it holds 
great potential to be developed into a nutritional and/or pharmacological 
therapeutics, as it stimulates mitochondrial respiration, glycolysis and lipolysis. In 
simple words, we could state that it suppresses gluconeogenesis and lipogenesis. 
These prominent pharmacological actions have been corroborated by numerous 
patents documented till date. Also, it is capable of eliciting broad spectrum beneficial 
biological effects, like analgesic, antipyretic, immunomodulator, antiviral, 
anthelmintic, antiallergic, antihistaminic, cardioprotective and antiamoebic, by 
modulating multiple targets [87].  
The futuristic research should be focussed on extensive mechanistic investigations 
into various other unexplored bioactivities, its complete pharmacokinetic 
exploration to establish ADME patterns, as well as on eagerly awaited pre-clinical 
and clinical evaluation of pure Mgf, its homologues and isomers, complex extracts or 
fractions from plants rich in xanthone C-glucosides. An important aspect of research 
that still needs to be undertaken is to elucidate the issues related to biosynthesis of 
Mgf and other hydroxyxanthones in plant cells, describing their physiological and 
endogenous role in plants and the change in content with environmental factors [88]. 
Detailed investigations and clinical trials, nevertheless, are needed to completely 
understand its exact mechanism of action against different malignancies and to fully 
exploit its potential therapeutic effects [89]. As it has low potency and 
bioavailability, it certainly needs extensive exploration in terms of structure-activity 
relationship studies. Cheminformatic tools can be used to carry out further studies 
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establishing the ostensible relationship of structure and activity amongst Mgf and its 
derivatives. Experimental evidence as well as predictive computational studies, done 
so far raise a possibility that Mgf could be developed into a multi-target drug. 
Considering the pertinent information gathered through such patents, Mgf certainly 
proves to be a promising candidate for futuristic research and development as a part 
of the multi-potent drug delivery systems. Hence, it seems to be a promising 
molecule holding ample scope for researchers to work further in its aspects, to 
unexplored so far. 
Conflicts of interest: 
The authors declare no conflict interest. 
 
Acknowledgement: 
Rajneet Kaur Khurana, Ranjot Kaur and Shikha Lohan acknowledge the University 
Grant Commission (UGC), New Delhi, India for financial grants to them. 
 
 
References: 
1. Bray F, Moller B. Predicting the future burden of cancer. Nat. Rev. Cancer. 6(1), 
63-74. (2006). 
2. Nersesyan H, Slavin KV. Current aproach to cancer pain management: 
Availability and implications of different treatment options. Ther. Clin. Risk 
Manag. 3(3), 381-400 (2007). 
3. Jayaprakash V, Marshall JR. Selenium and other antioxidants for 
chemoprevention of gastrointestinal cancers. Best Pract Res Clin. Gastroenterol. 
25(4-5), 507-518 (2011). 
4. Rodriguez J, Di Pierro D, Gioia M et al. Effects of a natural extract from 
Mangifera indica L, and its active compound, mangiferin, on energy state and 
lipid peroxidation of red blood cells. Biochim. Biophys. Acta. 1760(9), 1333-1342 
(2006).  
5. Leiro J, Arranz JA, Yanez M, Ubeira FM, Sanmartin ML, Orallo F. Expression 
profiles of genes involved in the mouse nuclear factor-kappa B signal 
transduction pathway are modulated by mangiferin. Int. Immunopharmacol. 
4(6), 763-778. (2004). ** (Elucidate anticancer mechanism of mangiferin ). 
6. Sarkar A, Sreenivasan Y, Ramesh GT, Manna SK. Beta-D-Glucoside 
suppresses tumor necrosis factor-induced activation of nuclear transcription 
factor kappaB but potentiates apoptosis. J. Biol. Chem. 279(32), 33768-33781 
(2004). 
23 
 
7. Ojewole JA. Antiinflammatory, analgesic and hypoglycemic effects of 
Mangifera indica Linn. (Anacardiaceae) stem-bark aqueous extract. Methods 
Find. Exp. Clin. Pharmacol. 27(8), 547-554 (2005). ** (Elucidate other activities of 
mangiferin ). 
 
8. Zhang BF, Jun; Chen, Yan. Antioxidant Effect of Mangiferin and its Potential 
to be a Cancer Chemoprevention Agent. Lett. Drug Des. Discov. 10, 239-244 
(2013). ** (Elucidate other activities of mangiferin  with their mechanisms). 
9. Matkowski A, Kus P, Goralska E, Wozniak D. Mangiferin - a bioactive 
xanthonoid, not only from mango and not just antioxidant. Mini Rev. Med. 
Chem. 13(3), 439-455 (2013). * (Elaborate basics of mangiferin). 
10. Sanchez GM, Re L, Giuliani A, Núñez-Sellés AJ, Davison GP, León-Fernández 
OS. Protective effects of Mangifera indica L. extract, mangiferin and selected 
antioxidants against TPA-induced biomolecules oxidation and peritoneal 
macrophage activation in mice. Pharmacol. Res. 42(6), 565–573 ( 2000). 
11. De Nysschen A. M., Van Wyk B.E., Van Heerden F. R., A.L. S. The major 
phenolic compounds in the leaves of Cyclopia species (honeybush tea). 
Biochem. Syst. Ecol. 24(3), 243–246 (1996). 
12. Kitanov GM, Nedialkov PT. Mangiferin and isomangiferin in some Hypericum 
species. Biochem. Syst. Eco. 26(6), 647–653 (1998). ** (Elaborate other isoforms 
of mangiferin). 
13. Fernández-Ponce MT, Casas L, Mantell C, RodrÃguez M, MartÃnez de la 
Ossa E. Extraction of antioxidant compounds from different varieties of 
Mangifera indica leaves using green technologies. J. Supercrit. Fluids. 72, 168–
175 (2012). 
14. Kulkarni VM, Rathod VK. Extraction of mangiferin from Mangifera indica 
leaves using three phase partitioning coupled with ultrasound. Ind. Crop. 
Prod. 52, 292–297 (2014). 
15. Benthin B, Danz H, Hamburger M. Pressurized liquid extraction of medicinal 
plants. J. Chromatogr. A. 837(1-2), 211-219 (1999). 
16. Kim W-J, Veriansyah B, Lee Y-W, Kim J, Kim J-D. Extraction of mangiferin 
from Mahkota Dewa (Phaleria macrocarpa) using subcritical water. J. Ind. 
Eng. Chem. 16(3), 425–430 (2010). 
17. Reverchon E, De Marco I. Supercritical fluid extraction and fractionation of 
natural matter. J. Supercrit. Fluids. 38(2), 146–166 (2006). 
18. Vrushali M. Kulkarni, Rathod VK. Extraction of mangiferin from Mangifera 
indica leaves using three phase partitioning coupled with ultrasound. Ind. 
Crop Prod. 52, 292– 297 (2014). 
19. Kulkarni VM, Rathod VK. A novel method to augment extraction of 
mangiferin by application of microwave on three phase partitioning. 
Biotechnol. Rep. 6, 8–12 (2015). 
20. Schieber A, Ullrich W, Carle R. Characterization of polyphenols in mango 
puree concentrate by HPLC with diode array and mass spectrometric 
detection. Innov. Food Sci. Emerg. Tech. 1(2), 161–166 (2000). 
24 
 
21. Abdalla AEM, Darwish SM, Ayad EHE, El-Hamahmy RM. Egyptian mango 
by-product 1. Compositional quality of mango seed kernel. Food. Chem. 103(4), 
1134–1140 (2007). 
22. Berardini N, Knodler M, Schieber A, Carle R. Utilization of mango peels as a 
source of pectin and polyphenolics. Innov. Food Sci. Emerg. Tech. 6(4), 442–452 
(2005). 
23. Nunez Selles AJ, Velez Castro HT, Aguero-Aguero J et al. Isolation and 
quantitative analysis of phenolic antioxidants, free sugars, and polyols from 
mango (Mangifera indica L.) stem bark aqueous decoction used in Cuba as a 
nutritional supplement. J. Agric. Food Chem. 50(4), 762-766 (2002). 
24. Raihan H. Mirza, Nan Chi, Chi Y. Therapeutic Potential of the Natural 
Product Mangiferin in Metabolic Syndrome. J. Nutr. Ther. 2, 74-79 (2013). * 
(Explain role of mangiferin in curbing diseases). 
25. Saleh NA, El-Ansari MA. Polyphenolics of twenty local varieties of Mangifera 
indica. Planta. Med. 28(2), 124-130 (1975). 
26. Andreu GP, Delgado R, Velho JA, Curti C, Vercesi AE. Iron complexing 
activity of mangiferin, a naturally occurring glucosylxanthone, inhibits 
mitochondrial lipid peroxidation induced by Fe2+-citrate. Eur. J. Pharmacol. 
513(1-2), 47-55 (2005). 
27. Britton RS, Leicester KL, Bacon BR. Iron toxicity and chelation therapy. Int. J. 
Hematol. 76(3), 219-228. (2002). 
28. Gilberto L. Pardo-Andreu, Renata A. Cavalheiro, Daniel J. Dorta et al. Fe(III) 
Shifts the Mitochondria Permeability Transition-Eliciting Capacity of 
Mangiferin to Protection of Organelle. J. Pharmacol. Exp. Ther. 320(2), 646-653 
(2007). 
29. Benard O, Chi Y. Medicinal properties of mangiferin, structural features, 
derivative synthesis, pharmacokinetics and biological activities. Mini Rev. 
Med. Chem. 15(7), 582-594 (2015). *(Holistic overview of mangiferin). 
30. Rajendran P, Rengarajan T, Nandakumar N, Divya H, Nishigaki I. Mangiferin 
in cancer chemoprevention and treatment: pharmacokinetics and molecular 
targets. J. Recept. Signal. Transduct. Res. 35(1), 76-84 (2015). * (Mechanistic 
understanding of mangiferin targeting on tumor cells). 
31. Agarwala S, Rao B, Mudholkar K, Bhuwania R, Rao S. Mangiferin, a dietary 
xanthone protects against mercury-induced toxicity in HepG2 cells. Environ. 
Toxicol. 27(2), 117-127, (2012). 
32. Stoilova I, Jirovetz L, Stoyanova A, Krastanov A, Gargova S, Ho L. 
Antioxidant activity of the polyphenol mangiferin. EJEAFChe. 713, 2706-2716 
(2008). 
33. Assim A, Alfadda, Sallam RM. Reactive Oxygen Species in Health and 
Disease. J. Biomed. Biotechnol. ID 936486, 1-14 (2012). 
34. Garcia-Rivera D, Delgado R, Bougarne N, Haegeman G, Berghe WV. Gallic 
acid indanone and mangiferin xanthone are strong determinants of 
immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-
MB231 breast cancer cells. Cancer Lett. 305(1), 21-31 (2011). 
25 
 
35. Delgado-Hernandez R, Magariño Y, Hernandez-Balmaseda et al. Anti-
angiogenic effects of Mangifera indica l. stem bark extract and its natural 
glucoxilxanthone, mangiferin. http://www.pa2online.org/abstracts/ 
vol10issue3abst089p.pdf. (Accessed on 06 January 2016). 
36. Daud NH, Aung CS, Hewavitharana et al. Mango extracts and the mango 
component mangiferin promote endothelial cell migration. J. Agri. Food Chem. 
58(8), 5181-5186. (2010). 
37. Pan LL, Wang AY, Huang YQ, Luo Y, Ling M. Mangiferin induces apoptosis 
by regulating Bcl-2 and Bax expression in the CNE2 nasopharyngeal 
carcinoma cell line. Asian Pac. J. Cancer Prev. 15(17), 7065-7068 ( 2014). 
38. Bartoszewski R, Hering A, Marszall M et al. Mangiferin has an additive effect 
on the apoptotic properties of hesperidin in Cyclopia sp. tea extracts. PLoS 
One. 9(3), e92128 (2014). 
39. Shoji K, Tsubaki M, Yamazoe Y et al. Mangiferin induces apoptosis by 
suppressing Bcl-xL and XIAP expressions and nuclear entry of NF-kappaB in 
HL-60 cells. Arch. Pharm. Res. 34(3), 469-475 (2011). 
40. du Plessis-Stoman D, du Preez J, van de Venter M. Combination treatment 
with oxaliplatin and mangiferin causes increased apoptosis and 
downregulation of NFkappaB in cancer cell lines. Afr. J. Tradit. Complement 
Altern. Med. 8(2), 177-184 (2011). 
41. Padma VV, Kalaiselvi P, Yuvaraj R, Rabeeth M. Mangiferin induces cell death 
against rhabdomyosarcoma through sustained oxidative stress. Integr. Med. 
Res. 4(2), 66-75 (2015). 
42. Li H, Huang J, Yang B et al. Mangiferin exerts antitumor activity in breast 
cancer cells by regulating matrix metalloproteinases, epithelial to 
mesenchymal transition, and beta-catenin signaling pathway. Toxicol. Appl. 
Pharmacol. 272(1), 180-190 (2013). 
43. Lv J, Wang Z, Zhang L et al. Mangiferin induces apoptosis and cell cycle arrest 
in MCF-7 Cells Both in vitro and in vivo. J. Anim. Vet. Adv. 12(3), 352-359 
(2013). 
44. Zasada I, Zajac D, Pozdzik M, Pokorski M. Influence of Mangiferin on Lipid 
Peroxidation Presented at: International Conference 'Advances in Pneumology’. 
Bonn, 17-18 June (2011). 
45. Kavitha M, Manivasagam T, Essa MM et al. Mangiferin antagonizes rotenone: 
induced apoptosis through attenuating mitochondrial dysfunction and 
oxidative stress in SK-N-SH neuroblastoma cells. Neurochem. Res. 39(4), 668-
676 (2014). 
46. Gupta SK: US 20040241114 A1 (2004). 
47. Gupta SK: US 20040156873 A1 (2004). 
48. Peter DW, Stanek JD, Orozco CL, Gupta SK: US 8410079 B2 (2013). 
49. Gupta SK, Walker L: US8227426 B2 (2012). 
50. Park D-S, Yoo MC, Choi D-Y et al: WO 2009104913 A3 (2009). 
51. Wang CC, Chen LG, Chang TL, Hsieh CT: US20110160152 A1 (2011). 
52. Truog P, Buschmann HH: EP2698156 A1 (2014). 
26 
 
53. Halbrook JW, Kesicki EA, Burgess LE, Schlachter ST, Eary CT, Schiro JG: WO 
2004085418 A3 (2005). 
54. Siegelin MD, Altieri DC: US 20110268722 A1 (2011). 
55. Gerk PM, Barr WH, Ritter JK: WO 2013049365 A3 (2013). 
56. Huang AL, Wu G: US 8716353 B1 (2014). 
57. Khwaja TA, Friedman EP: US 6113907 A (2000). 
58. Leonard J, Goldman S, O'hara Jr R: US 8012475 (2011). 
59. Omoigui O: US 20060078532 A1 (2006). 
60. Huang AL, Wu G: US 8722040 (2014). 
61. Huang AL, Wu G: (2013). 
62. Gupta SK: US 7615546 B2 (2009). 
63. Adam J, Dasse O, Parrott JA, Putman D: WO 2008100977 A3 (2008). 
64. Huang AL, Wu G: US 8822544 B2 (2014). 
65. Kim DH, Han MJ: WO 2014175543 A1 (2014). 
66. Talamond P, Mondolot L, Gargadennec A et al: WO/2009/125017 A3 (2009). 
67. Ueda F, Kakinuma C, Serizawa Y: WO/2010/035675 A1 (2010). 
68. Winter RW, Riscoe MK, Hinrichs DJ: US 6613797 (2003). 
69. Deshpande J, Ghanam K, Ewart S, Juturu V: US 20150141355 A1 (2015). 
70. Gupta SK: US 20120189567 (2012). 
71. Krishnan GG: US 8163312 (2012). 
72. Krishnan V: US 20080207774 A1 (2008). 
73. Auriol D, Nalin R, Robe P, Lefevre F: US 20140088030 A1 (2014). 
74. Matsuda H, Nishida S: JP2009023935 A (2009). 
75. Krishnan V: US 20080233062 (2008). 
76. Gupta SK, Walker L: US 8212076 (2012). 
77. Hoffmann E, Horres R, Faust V, Schreiber H, Von Holst A, Hoffmann M: US 
20110160698 A1 (2011). 
78. Ghosal S: WO/2006/078424 A2 (2006). 
79. Park D-s, Yoo MC, Choi D-y et al: US 20110003018 A1 (2011). 
80. Krishnan GG: US 20110236488 A1 (2011). 
81. Huang AL, Wu G: US 8716352 (2014). 
82. Thomas R: WO/2013/138871 A1 (2013). 
83. Deshpande J, Ghanam K, Ewart S, Juturu V: WO/2015/075549 (2015). 
84. Matute Almau C, Gomez MVS, Esparza RC et al: US 20090131339 A1 (2009). 
85. Chambers TJ, Fuller K, Jagger CJ, Lean JM: WO/2004/093995 A2 (2004). 
86. Khwaja TA, Friedman EP: WO/1997/039355 A1 (1997). 
87. Vyas A, Syeda K, Ahmad A, Padhye S, Sarkar FH. Perspectives on medicinal 
properties of mangiferin. Mini Rev. Med. Chem. 12(5), 412-425 (2012). 
88.       Acosta J, Sevilla I, Salomón S, Nuevas L, Romero A, Amaro D. Determination 
 of mangiferin solubility in solvents used in the biopharmaceutical industry. 
 JPPRes. 4(2), 49-53 (2016). 
89.     Li H, Wang Q,  Ding Y, Bao C , Li W. Mangiferin ameliorates Porphyromonas 
gingivalis induced experimental periodontitis by inhibiting phosphorylation 
of nuclear factor-kB and Janus kinase 1–signal transducer and activator of 
transcription signaling pathways. J. Periodont. Res. 1, 1-7 (2016). 
27 
 
 
